LILY Study launches to test monoclonal antibody treatment for celiac disease
This new phase 1 trial does not include a gluten challenge
09/20/2023
The world of celiac disease research changes and evolves each and every day. Beyond Celiac keeps the community up-to-date on research in many ways, including our Research News Feed and the Research Opt-In.
This new phase 1 trial does not include a gluten challenge
A recent study found that children who had detectable gluten in urine and stool samples did not have symptoms, backing up earlier evidence that symptoms are not reliable indicators of gluten getting into the gluten-free diet.
A group of international researchers has come up with a five-point scoring system for those with celiac disease to determine the risk of having persistent intestinal damage.
Results of research funded by Beyond Celiac point to a more precise way that gluten sets off damage to the intestine in those who have celiac disease and could help in the development of innovative approaches to finding a treatment.
Even celiac disease patients who were following a gluten-free diet and felt well were still unintentionally consuming some amount of gluten that was detected in stool tests, according to preliminary results of a study recently presented as a poster at Digestive Disease Week (DDW).
A potential celiac disease vaccine could one day be a reality. Whenever new information is available we update our Research News and our Celiac Disease Vaccine page.
Researchers around the world are working to develop new treatments for celiac disease. As a person affected by celiac disease, you can play an important role in advancing research by participating in clinical trials. View our Clinical Trials Infographic to learn how clinical trials tie into to drug development process.
Additionally, Beyond Celiac has been directly involved with assisting a number of clinical studies in all phases. With the largest celiac disease social community, a robust email and research database and a website that receives over 2 million visits a year, we are uniquely qualified to help your clinical trial recruit qualified candidates. Learn about our patient recruitment offerings.
Our Chief Scientific Officers lead the development and implementation of a transformational patient-centered research agenda focused on accelerating solutions toward new pharmaceutical treatments and a cure for celiac disease.
Our Chief Scientist and Strategy Officer develops our research and funding priorities to impact patients in areas including clinical decision-making about disease management, treatment, and eventually a cure.
Learn more about our Science Team, as well as our Medical Advisory Council and Scientific Advisory Board.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to